For the Inventor, By the Inventor

Enter inventor name

Ridgewood, NJ, United States of America

Ashok Tehim

USPTO Granted Patents = 71 (Patent Applications = 15)

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 9 (Patent Applications = 9)

Average Co-Inventor Count = 4.5

ph-index = 9

Forward Citations = 417(Granted Patents)

Inventors with similar research interests:

Location History:

Mississauga, CA (1996 - 2007)
Ridgewood, NJ (US) (2003 - 2019)

Company Filing History:

Memory Pharmaceuticals Corporation

Dr. Reddy's Laboratories, Incorporated

Allelix Biopharmaceuticals Inc.

Nps Allelix Corporation

Memory Pharmaceutical Corporation

Nps Pharmaceuticals, Inc.

Painceptor Pharma Corporation

8. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2019

Loading Chart...

Loading Chart...

Loading Chart...

71 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10344031 - Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors (2019-07-09),

2. 10131655 - Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists (2018-11-20),

3. 10047087 - Substituted pyrazolo[1,5-A] pyridine as tropomyosin receptor kinase (TrK) inhibitors (2018-08-14),

4. 9782391 - Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (TrkA) inhibitors (2017-10-10),

5. 9670207 - Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors (2017-06-06),

6. 9487510 - Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists (2016-11-08),

7. 9402833 - Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors (2016-08-02),

8. 9394305 - Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (TrkA) inhibitors (2016-07-19),

9. 9303027 - Kappa opioid receptor agonists (2016-04-05),

10. 9289419 - Substituted heterocyclic compounds as tropomyosin receptor kinase a (TrkA) inhibitors (2016-03-22),

11. 9045479 - Substituted heterocyclic compounds as tropomyosin receptor kinase a (TrkA) inhibitors (2015-06-02),

12. 9045478 - Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors (2015-06-02),

13. 8691841 - Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof (2014-04-08),

14. 8486937 - Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof (2013-07-16),

15. 8273891 - Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof (2012-09-25),

Title: The Innovative Mind of Ashok Tehim

Introduction: Ashok Tehim, a brilliant inventor hailing from Ridgewood, NJ (US), is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ashok Tehim's latest patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles, smart home technology, and renewable energy solutions.

Career Highlights: With over two decades of experience in the tech industry, Ashok Tehim has held key positions in various renowned tech companies, leading teams to develop innovative products and solutions. His expertise lies in merging technology with sustainability to create a positive impact on society.

Collaborations: Throughout his career, Ashok Tehim has collaborated with top researchers, engineers, and scientists from leading universities and research institutions worldwide. These collaborations have resulted in the development of revolutionary technologies that have shaped the future of various industries.

Conclusion: Ashok Tehim's passion for innovation, coupled with his relentless drive to push the boundaries of technology, has solidified his position as a visionary inventor in the ever-evolving tech landscape. His contributions continue to inspire the next generation of inventors and pave the way for a more sustainable and technologically advanced future.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…